JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schulz, R.
Right arrow Articles by Murphy, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schulz, R.
Right arrow Articles by Murphy, J.

Vol. 289, Issue 1, 599-606, April 1999

Effect of Phosducin on Opioid Receptor Function

Rüdiger Schulz, Andrea Wehmeyer, Karin Schulz and John Murphy

Institute of Pharmacology, Toxicology and Pharmacy (R.S., A.W.), Gene Center (K.S.), University of Munich, München, Germany; and Max-Planck-Institute for Biochemistry, Department of Cell Biology (J.M.), Martinsried, Germany

Phosducin (Phd) regulates the function of G proteins by its ability to tightly bind Gbeta gamma subunits. Because the internalization of opioid receptors as well as the activity of adenylyl cyclase (AC) activity depends on G proteins, we tested Phd on these parameters. NG 108-15 hybrid cells stably expressing the phosphoprotein were challenged with [D-penicillamine2,D-penicillamine5]enkephalin to inhibit cAMP generation, demonstrating an increased efficacy of the opioid on AC. Studying the binding of [35S]guanosine-5'-O-(gamma -thio)-triphosphate to membranes from Phd overexpressing cells, we found that [D-penicillamine2,D-penicillamine5 ]enkephalin failed, in the presence of Phd (0.1 nM), to elevate incorporation of the nucleotide. Phd also strongly inhibited opioid-stimulated GTPase activity. NG 108-15 cells were also employed to investigate the effect of Phd on opioid receptor internalization. Control cells and cells overexpressing Phd were transiently transfected to express µ-opioid receptors fused to green fluorescence protein. In controls and in Phd overexpressing cells confocal microscopy identified fluorescence associated with the membrane. Time-lapse series microscopy of living control cells challenged with etorphine (1 µM) revealed receptor internalization within 30 min. In contrast, Phd overexpressing cells largely failed to respond to the opioid. Thus, in Phd overexpressing cells, opioids exhibit an increased efficacy despite the inhibitory action of the phosphoprotein on opioid-stimulated incorporation of [35S]guanosine-5'-O-(gamma -thio)-triphosphate. We suggest that inhibition of GTPase stabilizes the opioid-induced G protein Gi-GTP complex, which is believed to enhance AC inhibition. Finally, scavenging of Gbeta gamma by Phd attenuates internalization of opioid receptors, which may contribute to the efficacy of opioids.


0022-3565/99/2891-0599$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
R. Schulz, A. Wehmeyer, and K. Schulz
Visualizing Preference of G Protein-Coupled Receptor Kinase 3 for the Process of kappa -Opioid Receptor Sequestration
Mol. Pharmacol., June 1, 2002; 61(6): 1444 - 1452.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Schulz, A. Wehmeyer, and K. Schulz
Opioid Receptor Types Selectively Cointernalize with G Protein-Coupled Receptor Kinases 2 and 3
J. Pharmacol. Exp. Ther., February 1, 2002; 300(2): 376 - 384.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.